Today 2026.08.05 D-43
Today 
|
Plenary Session 1 CAR T Cell Therapy Sep. 17 (Thu), 10:30-11:50 |
Room A (1F) |
|
|---|---|---|
| Chair(s) | Nack-Gyun Chung (College of Medicine, The Catholic University of Korea, Korea) | |
Current Real World Practice to Optimize Outcomes of CAR T Cell Therapy for Pediatric ALL
Children's Hospital of Philadelphia, USA
Eliminating GVHD Prophylaxis: A New Era of Sequential CAR-T and Allogeneic HSCT
The First Affiliated Hospital, Zhejiang University School of Medicine, China
|
Luncheon Symposium 1 Sep. 17 (Thu), 12:00-12:40 |
Room A (1F) |
|
|---|---|---|
| Chair(s) | Hee-Je Kim (College of Medicine, The Catholic University of Korea, Korea) | |
Optimizing cGVHD Management After Ruxolitinib Failure: The Role of Belumosudil in Clinical Practice
The First Affiliated Hospital of Soochow University, China
|
Luncheon Symposium 2 Sep. 17 (Thu), 12:00-12:40 |
Room C (2F) |
|
|---|---|---|
| Chair(s) | Seok Jin Kim (Sungkyunkwan University School of Medicine, Korea) | |
Maintaining Relative Dose Intensity in Elderly DLBCL: Clinical Strategies with Pegfilgrastim
Seoul National University Hospital, Korea
|
Luncheon Symposium 3 Sep. 17 (Thu), 12:00-12:40 |
Room D (2F) |
|
|---|---|---|
| Chair(s) | Deog-Yeon Jo (Chungnam National University College of Medicine, Korea) | |
Optimizing PNH Management with Iptacopan: Insights from Real-World Practice
College of Medicine, The Catholic University of Korea, Korea
|
Plenary Session 2 GVHD Sep. 17 (Thu), 13:00-14:20 |
Room A (1F) |
|
|---|---|---|
| Chair(s) | Hee-Je Kim (College of Medicine, The Catholic University of Korea, Korea) | |
Beyond Immunosuppression: Enhancing Tissue Resilience to Mitigate GVHD
Dan L. Duncan Comprehensive Cancer Center, USA
Immunologic Mechanisms and Modulation of Chronic Graft-Versus-Host Disease
University of Minnesota, USA
|
Joint Symposium 1 (ASTCT-KSBMT) Evolving T-cell Manipulation Strategies: Optimization of PTCy and New Frontiers in T Cell Depletion Sep. 17 (Thu), 14:30-16:00 |
Room A (1F) |
|
|---|---|---|
| Chair(s) |
Hyeon-Seok Eom (National Cancer Center, Korea) Margaret MacMillan (University of Minnesota, USA) |
|
Advances in Ex Vivo T Cell Depletion
University of Minnesota, USA
Selective T cell Depletion and Enrichment
Fred Hutchinson Cancer Center, USA
Optimizing T-Cell Modulation in Adult ALL Transplantation: ATG, PTCy, and Donor-Specific GVHD Control
College of Medicine, The Catholic University of Korea, Korea
|
Scientific Session 1 Next-Generation Immune Effector Cell Therapies: Emerging Platforms and Biological Insights Sep. 17 (Thu), 14:30-16:00 |
Room B (1F) |
|
|---|---|---|
| Chair(s) |
Seok Jin Kim (Sungkyunkwan University School of Medicine, Korea) Deok Hwan Yang (Chonnam National University Medical School, Korea) |
|
Biomarkers and Immune Fitness Shaping Outcomes of Immune Effector Cell Therapies
Dana-Farber Cancer Institute, USA
In Vivo CAR-T Engineering for Lymphoid Malignancies
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, China
Overcoming Resistance in T-cell Malignancies: From Phase 1 Study of CD5-targeted Allogeneic CAR-NK Cells
University of Ulsan College of Medicine, Korea
|
Scientific Session 2 Advances in Immunotherapy and Transplant Strategies in Pediatric Hematologic Malignancies Sep. 17 (Thu), 14:30-16:00 |
Room C (2F) |
|
|---|---|---|
| Chair(s) |
Keon Hee Yoo (Sungkyunkwan University School of Medicine, Korea) Jun Eun Park (Korea University College of Medicine, Korea) |
|
Virus-specific T Cells for Adoptive Immunotherapy
Dana-Farber Cancer Institute, USA
Strategies for Determining Treatment Flow of CAR T-Cell Therapy and HSCT in Pediatric ALL
Wroclaw Medical University, Poland
Clinical Applications of Donor Lymphocyte Infusion in Pediatric Malignancies
Sungkyunkwan University School of Medicine, Korea
|
Education Session 1 Additional Cellular Support after Allogeneic Transplantation Sep. 17 (Thu), 14:30-16:00 |
Room D (2F) |
|
|---|---|---|
| Chair(s) |
Yeung-Chul Mun (Ewha Womans University College of Medicine, Korea) Hyoung Soo Choi (Seoul National University College of Medicine, Korea) |
|
Management of Poor Graft Function in Chilren
Korea University College of Medicine, Korea
Donor Lymphocyte Infusion (DLI) in 2026: Indications, Dosing, and GVHD Trade-offs
University of Ulsan College of Medicine, Korea
Cellular Support Beyond the Graft: Integrative Strategis after Allogeneic HSCT
Case Western Reserve University School of Medicine, USA
|
Joint Symposium 2 (EBMT-KSBMT) Evolving Donor Issues in Allogeneic HSCT: From HLA Matching to Germline Screening and Emerging Concerns Sep. 17 (Thu), 16:50-18:30 |
Room A (1F) |
|
|---|---|---|
| Chair(s) |
Nack-Gyun Chung (College of Medicine, The Catholic University of Korea, Korea) Ibrahim Yakoub-Agha (Lille University Hospital, France) |
|
Germline Traits and Donor Selection for Allo-HCT: on Overview and the Paradigm of DDX41
University of Tor Vergata, Italy
Which Donor Should We Use in the Absence of a Matched Sibling in Aplastic Anemia?
La Fe University and Polytechnic Hospital, Spain
Clonal Hematopoiesis in Hematopoietic Stem Cell Transplantation
Seoul National University College of Medicine, Korea
Hematopoietic Stem Cell Donor Selection in 2026: Evolving Perspectives and Current Challenges
University of Ulsan College of Medicine, Korea
|
Scientific Session 3 Post-Transplant Residual Disease in Acute Leukemia: Monitoring and Therapeutic Strategies Sep. 17 (Thu), 16:50-18:20 |
Room B (1F) |
|
|---|---|---|
| Chair(s) |
Myungshin Kim (The Catholic University of Korea, Korea) Ho-Jin Shin (Pusan National University School of Medicine, Korea) |
|
Flow Cytometric MRD for AML: Updates in 2026
Amsterdam UMC, The Netherlands
Targeting Residual Disease after Transplant: The Convergence of HCT and Engineered Cellular Therapies
Columbia University Irving Medical Center, USA
Clinical Experience with NGS-based Chimerism Analyses in HSCT Patients
Yonsei University College of Medicine, Korea
|
Scientific Session 4 Science Behind Treatment Response and Relapse Sep. 17 (Thu), 16:50-18:20 |
Room C (2F) |
|
|---|---|---|
| Chair(s) |
Won-Sik Lee (Inje University College of Medicine, Korea) Sung-Soo Yoon (Seoul National University College of Medicine, Korea) |
|
Longitudinal Single-Cell Dissection of Venetoclax Resistance in Secondary AML
UNIST, Korea
Improving Post-transplant Immunological Outcome in AML by Modulating VISTA
Vanderbilt University Medical Center, USA
Immune Escape as a Mechanism of Post-transplant Relapse
Taussig Cancer Institute, USA
